Oral Session 2-13D MDS：Basic (3)

[OS2-13D-3] Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki

Masataka Taguchi¹, Hiroyuki Mishima², Yusuke Shiozawa³, Chisa Hayashida², Akira Kinoshita², Yasuhito Nanya³, Hideki Makishima³, Makiko Horai¹, Masatoshi Matsuo¹, Shinya Sato¹, Hidehiro Itonaga¹, Takeharu Kato¹, Hiroaki Taniguchi⁴, Daisuke Imanishi¹, Yoshitaka Imaizumi¹, Tomoko Hata¹, Motoi Takenaka⁵, Yukiyoshi Moriuchi⁴, Yuichi Shiraishi⁶, Satoru Miyano⁶, Seishi Ogawa³, Kohichiro Yoshiura², Yasushi Miyazaki¹ (1.Hematol., Atomic Bomb Disease Institute, Nagasaki Univ., Nagasaki, Japan, 2.Human Genetics, Atomic Bomb Disease Institute, Nagasaki Univ., Nagasaki, Japan, 3.Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 4.Hematol., Sasebo City General Hospital, Sasebo, Japan, 5.Department of Dermatology, Nagasaki University Hospital, Nagasaki, Japan, 6.Human Genome Center, University of Tokyo, Tokyo, Japan)